Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Chiltern announces it was selected as the partner CRO for Karolinska Development, a publicly-traded life sciences investment company that brings selects and develops the most commercially attractive medical innovations to the point of sales or out-licensing to other companies. The extensive CRO selection process began in 2012 and the company states it was selected based on its compatibility with Karolinska's needs for global infrastructure, and approach to deliver on innovation, quality and flexibility.
Read the full release here.